Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare Biotechnology

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger)

Bullboard Posts

Comment by themagicboxon Apr 28, 2020 8:53am

261 Views

Post# 30961003

RE:RE:PUB

Its already beat naproxen, as it produces similar COX inhibition and 1/6th the molar equivelance.
Now just has to beat placebo. Easy.

bringon10bagger wrote: Despite posters establishing doubt in peoples minds, mgmt would not have gone to the extreme of naming the drug, Dr. W. receiving accolades from the medical profession, performing/writing numerous articles h2s, recognized globally for his work, establishing key advisory people to see this to the endgame, whatever the results might be this will be going to next steps, we've already derisked to being the safest NSAID for its GI properties. Whatever dose works for pain reduction to equal Naproxen or better this will be headed to next steps.....PARTNERING......

Marky1 wrote: I just finished listening for a 2 nd time...I'm even more optimistic than I was before..ATB 346, I feel, is the real McCoy...Sure there are risks, as there is with any drug development.. but I feel that the risks

Are minimal. I've studied H2S ( honoured in Biochemistry) and it really does work in cellular healing

Good luck to all us brave investors..Hope my 5$ fills'´